Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析

◆英語タイトル:Inovio Pharmaceuticals Inc (INO) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1666
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Inovio Pharmaceuticals Inc (INO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. The company’s product pipeline includes VGX-3100 for the treatment of cervical HSIL, vulvar HSIL, anal HSIL; INO-5401for glioblastoma; INO-3107 for recurrent respiratory papillomatosis (RRP); MEDI0457 for head and neck cancer and INO-5151 for the treatment of Prostate cancer. The company also has platform development programs in partnerships with several companies and government bodies focused at developing therapeutics for infectious diseases such as HIV, ebola, zika virus, middle east respiratory syndrome (MERS), lassa fever and COVID-19 disease. Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc Key Recent Developments

Apr 02,2020 Australia’s CSIRO starts first stage of coronavirus vaccine testing
Mar 12,2020 INOVIO Pharmaceuticals reports 2019 fourth quarter and year-end financial results
Mar 04,2020 Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
Jan 31,2020 Coronavirus: Australia’s CSIRO aims to enable vaccine development

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Inovio Pharmaceuticals Inc – Key Facts
Inovio Pharmaceuticals Inc – Key Employees
Inovio Pharmaceuticals Inc – Key Employee Biographies
Inovio Pharmaceuticals Inc – Major Products and Services
Inovio Pharmaceuticals Inc – History
Inovio Pharmaceuticals Inc – Company Statement
Inovio Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Inovio Pharmaceuticals Inc – Business Description
Inovio Pharmaceuticals Inc – Corporate Strategy
Inovio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Inovio Pharmaceuticals Inc – Strengths
Inovio Pharmaceuticals Inc – Weaknesses
Inovio Pharmaceuticals Inc – Opportunities
Inovio Pharmaceuticals Inc – Threats
Inovio Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 02, 2020: Australia’s CSIRO starts first stage of coronavirus vaccine testing
Mar 12, 2020: INOVIO Pharmaceuticals reports 2019 fourth quarter and year-end financial results
Mar 04, 2020: Inovio Pharmaceuticals set to trial Covid-19 vaccine in April
Jan 31, 2020: Coronavirus: Australia’s CSIRO aims to enable vaccine development
Jan 30, 2020: Inovio collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus In China
Jan 29, 2020: VGXI to manufacture vaccine against Novel Coronavirus under CEPI funded collaboration
Jan 24, 2020: Coronavirus: Inovio and Moderna get CEPI funding to develop vaccine
Jan 15, 2020: Inovio welcomes biotech leader to its board of directors
Jan 07, 2020: BLS Pharma alleges Inovio’s breach of contract obstructed ability to deliver testosterone replacement therapy for hypogonadism and the transgender community
Jan 06, 2020: Inovio provides update on clinical program plans for 2020
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Inovio Pharmaceuticals Inc, Key Facts
Inovio Pharmaceuticals Inc, Key Employees
Inovio Pharmaceuticals Inc, Key Employee Biographies
Inovio Pharmaceuticals Inc, Major Products and Services
Inovio Pharmaceuticals Inc, History
Inovio Pharmaceuticals Inc, Other Locations
Inovio Pharmaceuticals Inc, Subsidiaries
Inovio Pharmaceuticals Inc, Key Competitors
Inovio Pharmaceuticals Inc, Ratios based on current share price
Inovio Pharmaceuticals Inc, Annual Ratios
Inovio Pharmaceuticals Inc, Annual Ratios (Cont...1)
Inovio Pharmaceuticals Inc, Interim Ratios
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Inovio Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Inovio Pharmaceuticals Inc, Ratio Charts
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Inovio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Inovio Pharmaceuticals Inc (INO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nativis Inc-医療機器分野:企業M&A・提携分析
    Summary Nativis Inc (Nativis) is a clinical stage bio-electronics company. Its portfolio of pipeline candidates which are under development for various therapeutic areas include recurrent glioblastoma, brain metastisis, pain, rheumatoid arthritis, lung cancer and melanoma. The company’s lead product …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Fnm Spa:企業の戦略・SWOT・財務分析
    Fnm Spa - Strategy, SWOT and Corporate Finance Report Summary Fnm Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • The J.M. Smucker Co:企業の戦略・SWOT・財務分析
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Evoke Pharma Inc (EVOK):企業の財務・戦略的SWOT分析
    Summary Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions fo …
  • Bicycle Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bicycle Therapeutics Ltd (Bicycle Therapeutics) is a biotechnology company that develops bicyclic peptides Medicines for the treatment of cancers and other debilitating diseases. The company's proprietary bicyclic peptide technology enables systematic cyclisation of peptides and helps to ide …
  • Mercer LLC:企業のM&A・事業提携・投資動向
    Mercer LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mercer LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Onduline SA:企業の戦略・SWOT・財務情報
    Onduline SA - Strategy, SWOT and Corporate Finance Report Summary Onduline SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cimentos de Portugal SGPS SA:企業の戦略的SWOT分析
    Cimentos de Portugal SGPS SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • MicuRx Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • SK Telecom Co., Ltd.:戦略・SWOT・企業財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Patel Engineering Ltd:企業の戦略・SWOT・財務分析
    Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Patel Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Plus Therapeutics Inc (PSTV):企業の財務・戦略的SWOT分析
    Plus Therapeutics Inc (PSTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • The Emirates Group:企業の戦略・SWOT・財務情報
    The Emirates Group - Strategy, SWOT and Corporate Finance Report Summary The Emirates Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Probiodrug AG (PBD)-製薬・医療分野:企業M&A・提携分析
    Summary Probiodrug AG (Probiodrug) is a biopharmaceutical company that conducts research and development of therapies for Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a small molecule glutaminyl cyclase (QC) i …
  • Fluor Corp (FLR):企業の財務・戦略的SWOT分析
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tokyo Electron Limited:企業の戦略・SWOT・財務分析
    Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report Summary Tokyo Electron Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆